लोड हो रहा है...

Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma: Case report

RATIONALE: Nivolumab (Nivo) is an immune checkpoint inhibitor that has been used to treat advanced melanoma, nonsmall cell lung carcinoma, and renal cell carcinoma since 2015. Nivo is associated with several side effects, including hepatitis, pneumonitis, acute renal failure, endocrine disorder, and...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Medicine (Baltimore)
मुख्य लेखकों: Chen, Yu-Hsiu, Liu, Feng-Cheng, Hsu, Chang-Hung, Chian, Chih-Feng
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Wolters Kluwer Health 2017
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5502156/
https://ncbi.nlm.nih.gov/pubmed/28682883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000007350
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!